Purchase Order 75N91024P00518

Award Date 6/26/24
Potential Completion Date 7/25/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $89,418.97, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. Societal Cdmo San Diego is a small disadvantaged business that specializes in pharmaceutical product development, manufacturing, and testing services for the federal government. The contract is for "SPECIAL...
This is a delivery order awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. The $127,330 cost-plus-fixed-fee contract is for special studies and analysis related to chemical and biological agents. The contract has no set-aside designation. Societal Cdmo San Diego is a small disadvantaged business that provides pharmaceutical development, manufacturing, and testing...
This is a federal contract awarded by the National Cancer Institute (NCI), an agency within the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. The $132,775 cost-plus-fixed-fee contract is for the provision of special studies and analysis related to chemical and biological manufacturing. The contract has no set-aside designation. Societal Cdmo San Diego is a small disadvantaged business that provides pharmaceutical development,...
The federal contract award was issued by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and limited liability company. The $132,422 cost-plus-fixed-fee contract is for the clinical supply of drug products, including oral and topical dosage forms, to support NCI's research and development efforts, particularly in the areas of...
This is a federal contract award to Societal Cdmo San Diego, LLC, doing business as Irisys Inc., a small disadvantaged business contract development and manufacturing organization (CDMO). The $9,916 cost-plus-fixed-fee delivery order contract was awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, for the development and manufacture of oral and topical dosage forms. The contract is not associated with a set-aside program. Under this award,...
This is a federal contract award to Societal Cdmo San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and contract development and manufacturing organization (CDMO). The $82,758 cost-plus-fixed-fee delivery order, awarded by the National Cancer Institute (NCI), is for the production of AZA-TD-CYD capsules for clinical use. The contract has no set-aside designation and is part of the $45 million Drug Formulation and Manufacturing Contracts 2019...
This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC, doing business as Irisys Inc. The $79,764 contract is for the clinical supply of an oral and topical drug product under a delivery order contract. The work is related to the NCI's oncology drug development efforts. Societal CDMO San Diego is a small disadvantaged business that provides contract pharmaceutical development,...
This federal contract award was issued by the National Cancer Institute, a component of the Department of Health and Human Services, to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The $80,834.00 contract is for the provision of IPDR Capsules, 600mg strength, under a cost-plus-fixed-fee type delivery order. Societal CDMO San Diego produces various drug formulations, including oral capsules, injectable solutions, and nasal sprays, to...
This is a $17,542 Cost Plus Fixed Fee delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The contract is for the production and evaluation of the stability of tetrathiomolibdate capsules in a non-GMP study. This award is part of Societal CDMO San Diego's work...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. The $156,438.00 contract is for the provision of special studies and analysis related to chemical and biological manufacturing, particularly in support of the NCI's oral and topical dosage form development efforts. The...

This federal contract award, valued at $13,375.00, was issued by the National Cancer Institute (NCI) to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business organized as a for-profit limited liability company.

The contract represents a ratification of an unauthorized commitment and is a firm-fixed price purchase order with a completion date of July 25, 2024. Societal CDMO San Diego, LLC has held several indefinite delivery/indefinite quantity (IDIQ) contract vehicles with the National Institutes of Health (NIH) and Department of Veterans Affairs to provide pharmaceutical development, manufacturing, testing, and research services, including for oncology, neurology, addiction, and rare disease therapies. This award is not associated with a set-aside program.

Generated 7/2/24, 2:00 PM